Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CircuLite Aims To Transform HF Treatment With Miniature Blood Pump

This article was originally published in The Gray Sheet

Executive Summary

CircuLite, a New Jersey start-up, aims to begin a U.S. clinical trial next year for a new treatment option for chronic heart failure patients

You may also be interested in...



Research In Brief

CircuLite: NIH will grant CircuLite up to $3.7 million in a Fast-Track Phase I-II Small Business Innovation Research Grant to develop a pediatric circulatory assist device based on the same technology as the firm's Synergy Pocket Micro-pump, a small impeller-driven ventricular assist device about the size of a AA battery. Saddle Brook, N.J.-based CircuLite will collaborate with the University of Maryland School of Medicine on the project. CircuLite is currently conducting a European trial of Synergy Pocket Micro-pump (1"The Gray Sheet" Sept. 17, 2007)

Research In Brief

CircuLite: NIH will grant CircuLite up to $3.7 million in a Fast-Track Phase I-II Small Business Innovation Research Grant to develop a pediatric circulatory assist device based on the same technology as the firm's Synergy Pocket Micro-pump, a small impeller-driven ventricular assist device about the size of a AA battery. Saddle Brook, N.J.-based CircuLite will collaborate with the University of Maryland School of Medicine on the project. CircuLite is currently conducting a European trial of Synergy Pocket Micro-pump (1"The Gray Sheet" Sept. 17, 2007)

NIH Group Proposes Ventricular Assist Study For “Less Sick” Patients

The National Heart Lung and Blood Institute and an interdisciplinary team of experts is trying to develop a multi-device clinical trial to test the benefits of ventricular assist devices in patients with advanced, but not end-stage, heart failure

Related Content

UsernamePublicRestriction

Register

OM001644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel